Showing 1 - 10 of 1,735
Introduction: Common approaches in cost-effectiveness analyses do not adjust for confounders. In nonrandomized studies this can result in biased results. Parametric models such as regression models are commonly applied to adjust for confounding, but there are several issues which need to be...
Persistent link: https://www.econbiz.de/10009783264
Cost-effectiveness analysis is versatile and used widely to assist in health care decision making. This chapter discusses how cost-effectiveness analysis is used at the system or national level, particularly in the domain of coverage and payment policy. We describe its relationship to other...
Persistent link: https://www.econbiz.de/10014025580
endogeneity of spending in a flexible copula regression model with Bernoulli and Tweedie margins and discuss its implementation in …
Persistent link: https://www.econbiz.de/10013256650
This paper considers a parametric model for the joint distribution of income and wealth. The model is used to analyze income and wealth inequality in five OECD countries using comparable household-level survey data. We focus on the dependence parameter between the two variables and study whether...
Persistent link: https://www.econbiz.de/10011295514
, employing a copula approach to model specification. In taking this approach the model flexibly accounts for any statistical …
Persistent link: https://www.econbiz.de/10014181400
Cost-effectiveness analysis often plays an important role in prioritization among different types of public health expenditures. Cost-effectiveness is defined as the maximal health benefits for given expenditures on health care. With a private health sector as a supplement to the public sector,...
Persistent link: https://www.econbiz.de/10010284383
Background: The Fracture Intervention Trial (FIT) showed that the bisphosphonate alendronate reduces the risk of fractures in women with low bone mass in the United States. Objective: To estimate the cost-effectiveness (cost per life-year gained and cost per quality-adjusted life-year, QALY,...
Persistent link: https://www.econbiz.de/10001673640
Objective: To estimate the cost-effectiveness for Colombia of four asymptomatic-bacteriuria (ABU) screening alternatives in pregnant women: a) urine culture, b) Gram stain, c) urianalysis and d) urianalysis followed by urine culture after a positive result.Methods: Two decision trees were built...
Persistent link: https://www.econbiz.de/10013089221
Methods: A decision tree model was built with life years gained as outcome, from the perspective of the health system, and including all direct costs. Pharmaceutical prices were obtained from the System of Information of Medicaments SISMED (2008), and the value of procedures was calculated from...
Persistent link: https://www.econbiz.de/10013089226
Millions Saved (2016) is a new edition of detailed case studies on the attributable impact of global health programs at scale. As an input to the book, this paper provides an independent assessment of the cost-effectiveness of a selection of the cases using ex post information from impact...
Persistent link: https://www.econbiz.de/10012983136